Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL): Clinical Features, Treatment, and Outcome. a Single Institution Result of 145 Patients from the Middle East

被引：0
|
作者：
Akhtar, Saad
Al-Kofide, Amani
Bakshi, Nasir
Shamayel, Mohammed
Khafaga, Yasser
Al-Sweedan, Suleimman
Elhassan, Tusneem
Rauf, M. S.
Maghfoor, Irfan
机构：
来源：
BLOOD | 2017年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2794
引用
收藏
页数：3
相关论文
共 47 条
  • [41] NODULAR LYMPHOCYTE PREDOMINANT HODGKIN LYMPHOMA BEHAVES AS A DISTINCT CLINICAL ENTITY WITH GOOD OUTCOME: EVIDENCE FROM 14 YEAR FOLLOW-UP FROM THE WEST OF SCOTLAND CANCER NETWORK
    Farrell, K.
    Mckay, P.
    Leach, M.
    ANNALS OF ONCOLOGY, 2011, 22 : 181 - 181
  • [42] Nodular lymphocyte predominant Hodgkin lymphoma behaves as a distinct clinical entity with good outcome: evidence from 14-year follow-up in the West of Scotland Cancer Network
    Farrell, Katrina
    McKay, Pamela
    Leach, Mike
    LEUKEMIA & LYMPHOMA, 2011, 52 (10) : 1920 - 1928
  • [43] Extended field radiotherapy, combined modality treatment or involved field radiotherapy for patients with stage 1A lymphocyte-predominant Hodgkin's lymphoma:: a retrospective analysis from the German Hodgkin Study Group (GHSG)
    Nogová, L
    Reineke, T
    Eich, HT
    Josting, A
    Müller-Hermelink, HK
    Wingbermühle, K
    Brillant, C
    Gossmann, A
    Oertel, J
    Bollen, MV
    Müller, RP
    Diehl, V
    Engert, A
    ANNALS OF ONCOLOGY, 2005, 16 (10) : 1683 - 1687
  • [44] Comparison of initial characteristics and long-term outcome of patients with lymphocyte-predominant Hodgkin lymphoma and classical Hodgkin lymphoma at clinical stages IA and IIA prospectively treated by brief anthracycline-based chemotherapies plus extended high-dose irradiation
    Feugier, P
    Labouyrie, E
    Djeridane, M
    Jenabian, A
    Dubruille, V
    Berthou, C
    Ghandour, C
    Desablens, B
    Chaït, Y
    Casassus, P
    Delwail, V
    Ifrah, N
    Le Mevel, A
    Lamy, T
    Brière, J
    Colonna, P
    Andrieu, JM
    BLOOD, 2004, 104 (09) : 2675 - 2681
  • [45] Clinical Features and Treatment Outcomes of Patients With Primary Systemic Anaplastic Large Cell Lymphoma: Report From a Single Institution in China
    Zhang, X.
    Li, Y.
    Wang, S.
    Wang, W.
    Jin, J.
    Liu, Y.
    Song, Y.
    Liu, X.
    Zhou, L.
    Yu, Z.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S616 - S617
  • [46] Excellent Outcome of Nodular Lymphocyte Predominant Hodgkin Lymphoma in the Eastern Province of Saudi Arabia. a Real-World Case Series of 49 Consecutive Patients Treated at a Referral Center from 2006 to 2017
    Apostolidis, John
    Mokhtar, Nihad
    Darweesh, Mohammed
    Mutahar, Enas
    Abdulbaqi, Manar
    Harbi, Salman
    Shaibani, Eshrak
    Kawari, Mohammed
    Abulhassan, Ayman
    Bacal, Jenifer
    Raslan, Heba
    Dawood, Afrah
    Moinuddid, Asif
    Buali, Ahmed
    Debawy, Eman
    Hindi, Taghreed
    Garni, Ayed
    Rahal, Mohammed
    Kaloyannidis, Panagiotis
    Anezi, Khalid
    Al Hashmi, Hani Hassan
    BLOOD, 2018, 132
  • [47] Clinical features and treatment outcomes of opportunistic infections among human T-Iymphotrophic virus type 1 (HTLV-1) carriers and patients with adult T-cell leukemia-lymphoma (ATL) at a single institution from 2006 to 2016
    Kawano, Noriaki
    Nagahiro, Yuri
    Yoshida, Shuro
    Tahara, Yoshihiro
    Himeji, Daisuke
    Kuriyama, Takuro
    Tochigi, Taro
    Nakaike, Takashi
    Shimokawa, Tomonori
    Yamashita, Kiyoshi
    Ochiai, Hidenobu
    Marutsuka, Kouske
    Mashiba, Koichi
    Shimoda, Kazuya
    Teshima, Takanori
    Kikuchi, Ikuo
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEMATOPATHOLOGY, 2019, 59 (04) : 156 - 167
12345